HQIP / Resources / National Oesophago-Gastric Cancer Audit report 2015
National Oesophago-Gastric Cancer Audit report 2015
Published: 17 Dec 2015
This National Oesophago-Gastric Cancer Audit report 2015 calls for more high-grade dysplasia patients to undergo pioneering treatment, finding that a quarter of patients who are found to have abnormal cells in their food pipe, are not undergoing pioneering treatment which could prevent them from developing cancer.
Today’s publication also finds that:
The proportion of patients diagnosed with O-G cancer after an emergency admission has decreased since 2010, from 15.3 per cent to 13.6 per cent. Patients diagnosed as a result of an emergency are less likely to be able to have curative treatment, so this is a positive development
The proportion of patients offered curative treatment has increased from 36 per cent to 38 per cent, but the figure varied from 33 per cent to 45 per cent across regional networks
The 90-day postoperative mortality rate for both oesophagectomy and gastrectomy has fallen to 4.3 per cent and 4.2 per cent respectively from 5.7 per cent and 6.9 per cent in 2010
High grade dysplasia (HGD) is a condition in which cells in the lining of the food-pipe or oesophagus, become severely abnormal*. These cell changes can lead to oesophageal cancer – if left untreated, around 1 in 20 patients with HGD develop this type of cancer each year.